Latest News
Stock Market Investing for Beginners: A Safe Start Without Major Losses
New investors should avoid using essential funds, pay off high-interest debt, and start with low-cost index funds or ETFs, as advised by regulators and Warren Buffett.
S&P 500 and Nasdaq Close at Record Highs; Dow Edges Lower
The S&P 500 and Nasdaq closed at all-time highs on Monday, while the Dow Jones Industrial Average declined. Nvidia's market cap topped $5 trillion, and Domino's Pizza dropped after forecasting slower growth. Markets are focused on upcoming earnings and the Federal Reserve's policy announcement.
Youxin Technology Soars 150% on $10.8M TikTok Stake Deal
Youxin Technology shares jumped 149.62% Monday after the company agreed to acquire an 18% stake in TikTok commerce partner YATOP for $10.8 million in stock.
VIX Dips to 18.02 as S&P 500 and Nasdaq Hit Records, but Futures Signal Caution
The VIX slipped to 18.02 on Monday even as the S&P 500 and Nasdaq hit record highs, but futures above 20 suggest traders remain hedged amid earnings and geopolitical risks.
Gold Retreats Below $4,700 as Fed Meeting and Iran Tensions Weigh
Gold slipped under $4,700 on Monday, pressured by Fed policy uncertainty and stalled diplomatic talks with Iran. Analysts raised 2026 forecasts to a record $4,916, but technical signals show fading momentum.
Tesla Stock Edges Up After Musk's $115B Share Filing; Capex and Robotaxi Plans in Focus
Tesla (TSLA) shares closed at $378.67, up 0.6%, after registering 303.96 million shares linked to Elon Musk's 2018 CEO award, valued at $114.65 billion. The market weighed dilution concerns against Tesla's $25 billion 2026 capex plan and robotaxi timeline.
Interstellar Comet 3I/ATLAS Bears Water Signature from Frigid Exoplanetary System
ALMA measurements of deuterated water in interstellar comet 3I/ATLAS show a D/H ratio over 40 times Earth's oceans, indicating origin in a far colder system.
Stanley Black & Decker Shares Surge on $500M Buyback Plan
Stanley Black & Decker shares climbed 4% to $79.86 after the board approved a $500 million buyback and kept the quarterly dividend at $0.83 per share. Q1 results are due Wednesday.
Oruka Therapeutics Soars on Psoriasis Drug Data, Announces $500M Offering
Oruka Therapeutics shares surged after interim data showed its psoriasis drug ORKA-001 achieved 63.5% complete skin clearance. The company also announced a $500M public offering.
Rambus Stock Declines Despite AI-Driven Revenue Growth in Q1
Rambus shares dropped 10.8% after Q1 earnings, despite product revenue climbing 15% on AI demand. The company's cautious Q2 outlook tied to customer deals tempered investor enthusiasm.